| dc.contributor.author | Akbari, Mohammad Esmail | en_US |
| dc.contributor.author | Rohani- Rasaf, Marzieh | en_US |
| dc.contributor.author | Nafissi, Nahid | en_US |
| dc.contributor.author | Akbari, Atieh | en_US |
| dc.contributor.author | Shojaee, leyla | en_US |
| dc.date.accessioned | 1399-07-08T17:56:23Z | fa_IR |
| dc.date.accessioned | 2020-09-29T17:56:23Z | |
| dc.date.available | 1399-07-08T17:56:23Z | fa_IR |
| dc.date.available | 2020-09-29T17:56:23Z | |
| dc.date.issued | 2018-04-01 | en_US |
| dc.date.issued | 1397-01-12 | fa_IR |
| dc.date.submitted | 2017-09-07 | en_US |
| dc.date.submitted | 1396-06-16 | fa_IR |
| dc.identifier.citation | Akbari, Mohammad Esmail, Rohani- Rasaf, Marzieh, Nafissi, Nahid, Akbari, Atieh, Shojaee, leyla. (2018). Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases. Asian Pacific Journal of Cancer Prevention, 19(4), 949-953. doi: 10.22034/APJCP.2018.19.4.949 | en_US |
| dc.identifier.issn | 1513-7368 | |
| dc.identifier.issn | 2476-762X | |
| dc.identifier.uri | https://dx.doi.org/10.22034/APJCP.2018.19.4.949 | |
| dc.identifier.uri | http://journal.waocp.org/article_59589.html | |
| dc.identifier.uri | https://iranjournals.nlai.ir/handle/123456789/32608 | |
| dc.description.abstract | Background: Recurrence of breast cancer after treatment is generally due to loco-regional invasion or distant<br />metastasis. Although patients with metastasis are considered incurable, existing treatments might prolong a patient's life<br />while also improving its quality. Choice of approach for individual patients requires identification of relevant survival<br />factors. This study concerns factors influencing survival after recurrence in Iranian breast cancer patients. Methods: This<br />study was performed on 442 recurrent breast cancer patients referred to the Cancer Research Center of Shahid Beheshti<br />University between 1985 and 2015. After confirming recurrence as a distant metastasis or loco-regional invasion, the<br />effects of demographic, clinic-pathologic, biological, type of surgery and type of adjuvant treatment on survival were<br />evaluated using univariate and multivariate stratified Cox models. Results: The mean survival after recurrence was<br />18 months (5 days to 13 years), 219 patients (70.42%) survived two years, 75 patients (24.12%) survived from 2 to 5<br />years, and 17 patients (5.47%) survived more than 5 years. In this study, it was found through univariate analysis that the<br />factors of age, lymph node status, DFI, place of recurrence and nodal ratio demonstrated greatest influence on survival<br />after recurrence. On multivariate analysis, the most important factors influencing survival were the place of recurrence<br />and the lymph node status. Conclusion: The results of this study enhance our knowledge of effects of different factors<br />on survival of patients after breast cancer recurrence. Thus, they may be used to inform treatment choice. | en_US |
| dc.format.extent | 343 | |
| dc.format.mimetype | application/pdf | |
| dc.language | English | |
| dc.language.iso | en_US | |
| dc.publisher | West Asia Organization for Cancer Prevention (WAOCP) | en_US |
| dc.relation.ispartof | Asian Pacific Journal of Cancer Prevention | en_US |
| dc.relation.isversionof | https://dx.doi.org/10.22034/APJCP.2018.19.4.949 | |
| dc.subject | Recurrent breast cancer | en_US |
| dc.subject | survival | en_US |
| dc.subject | Prognosis | en_US |
| dc.subject | Cancer biology | en_US |
| dc.title | Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases | en_US |
| dc.type | Text | en_US |
| dc.type | Research Articles | en_US |
| dc.contributor.department | Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. | en_US |
| dc.contributor.department | School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran. | en_US |
| dc.contributor.department | Department of surgery, Iran University of Medical Sciences, Tehran, Iran. | en_US |
| dc.contributor.department | Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. | en_US |
| dc.contributor.department | Department of Surgery, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran. | en_US |
| dc.citation.volume | 19 | |
| dc.citation.issue | 4 | |
| dc.citation.spage | 949 | |
| dc.citation.epage | 953 | |